A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer
about
Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer.Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumabCapecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
P2860
A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A phase II study of oxaliplati ...... f metastatic colorectal cancer
@ast
A phase II study of oxaliplati ...... f metastatic colorectal cancer
@en
type
label
A phase II study of oxaliplati ...... f metastatic colorectal cancer
@ast
A phase II study of oxaliplati ...... f metastatic colorectal cancer
@en
prefLabel
A phase II study of oxaliplati ...... f metastatic colorectal cancer
@ast
A phase II study of oxaliplati ...... f metastatic colorectal cancer
@en
P2093
P2860
P1476
A phase II study of oxaliplati ...... f metastatic colorectal cancer
@en
P2093
Gerard C Blobe
Herbert I Hurwitz
Herbert Pang
Johanna C Bendell
Michael A Morse
Nan Soon Wong
Nishan H Fernando
Wanda Honeycutt
P2860
P304
P356
10.1016/J.CLCC.2011.03.018
P407
P577
2011-04-24T00:00:00Z